Giovanni Solinas
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Loss of hepatocyte PI3Kα reduces hepatocellular carcinoma and hepatocyte proliferation in association with altered lipid metabolism.
Journal: JHEP reports : innovation in hepatology
Published: September 11, 2025
Harnessing insulin biology to treat diabetes and cancer.
Journal: Science (New York, N.Y.)
Published: July 24, 2025
Prevention of insulin-induced lipohypertrophy by coadministration of a low dose of high-affinity PI3K inhibitors.
Journal: Metabolism: clinical and experimental
Published: January 16, 2025
Ablation of PI3Kγ in neurons protects mice from diet-induced obesity MASLD and insulin resistance.
Journal: iScience
Published: August 26, 2024
Response to Comment on Mittendorfer et al. Insulin Hypersecretion as Promoter of Body Fat Gain and Hyperglycemia. Diabetes 2024;73:837-843.
Journal: Diabetes
Published: August 15, 2024
Insulin Hypersecretion as Promoter of Body Fat Gain and Hyperglycemia.
Journal: Diabetes
Published: December 05, 2023
An adipoincretin effect links adipostasis with insulin secretion.
Journal: Trends in endocrinology and metabolism: TEM
Published: July 14, 2023
PI3K and AKT at the Interface of Signaling and Metabolism.
Journal: Current topics in microbiology and immunology
Published: October 15, 2022
Tubular IKKβ Deletion Alleviates Acute Ischemic Kidney Injury and Facilitates Tissue Regeneration.
Journal: International journal of molecular sciences
Published: July 06, 2022
PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation.
Journal: JHEP reports : innovation in hepatology
Published: February 08, 2021
Last Updated: 09/26/2026